Valuation: Vystar Corp

Market Cap 4.05M 3.55M 3.28M 3.03M 5.75M 388M 5.86M 39.45M 15.33M 190M 15.22M 14.89M 659M P/E 2024
0.63x
P/E 2025 -0.58x
Enterprise Value 5.13M 4.5M 4.15M 3.84M 7.28M 491M 7.42M 49.94M 19.41M 240M 19.27M 18.84M 835M EV / Sales 2024
13.1x
EV / Sales 2025 39.9x
Free-Float
93.05%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 58 21/12/2023
Director TitleAgeSince
Director/Board Member 58 17/12/2017
Chairman 46 14/02/2018
Director/Board Member 58 21/12/2023
Change 5-day change 1-year change 3-year change Capi.($)
-20.79%-20.00% - - 4.05M
-1.38%+4.40%+4.03%+36.70% 95.26B
-0.90%+2.68%-7.88%+46.11% 68.44B
-1.46%+1.55%-10.35% - 22.87B
+1.02%+3.52%+29.61%+75.11% 15.74B
-0.45%+5.52%-15.34%-8.24% 8.03B
-1.23%+2.40%+10.33%+7.73% 7.02B
-2.65%-4.91%+52.75%+60.46% 6.01B
-3.11%-11.21%+47.94%+84.06% 4.63B
+1.00%+11.07%+37.53%-14.41% 2.97B
Average -2.87%+2.48%+16.51%+35.94% 25.66B
Weighted average by Cap. -0.83%+4.64%+2.92%+41.00%

Financials

2024 2025
Net sales 136K 119K 110K 102K 193K 13.02M 197K 1.32M 514K 6.37M 511K 499K 22.12M 54.82K 48.08K 44.39K 41.02K 77.75K 5.25M 79.31K 534K 207K 2.57M 206K 201K 8.92M
Net income 760K 666K 615K 568K 1.08M 72.72M 1.1M 7.39M 2.87M 35.59M 2.85M 2.79M 124M -1.53M -1.34M -1.24M -1.15M -2.17M -147M -2.22M -14.91M -5.79M -71.77M -5.75M -5.63M -249M
Net Debt 1.15M 1.01M 932K 861K 1.63M 110M 1.67M 11.21M 4.35M 53.94M 4.32M 4.23M 187M 1.08M 945K 873K 807K 1.53M 103M 1.56M 10.49M 4.08M 50.51M 4.05M 3.96M 175M
Logo Vystar Corp
Vystar Corporation is the owner and manufacturer of multiple brands of eco-friendly products for the home, office and medical sectors. The Company is focused on three main brands: Vytex, RXAIR, and Fluid Energy Conversion (FEC). The Company uses patented technology to produce a line of air purifiers, which destroy viruses and bacteria through the use of ultraviolet light. It is also the creator and owner of Vytex Natural Rubber Latex (NRL), being used primarily in toppers and in various bedding products. RxAir is the manufacturer of air purification systems in the world and a developer, manufacturer and distributor of biotechnology products targeting the indoor air quality (IAQ) industry sector. RxAir’s products include the RxAir purification system for the home as well as lines of hospital-grade HEPA filtration products. All of its products are Food and Drug Administration (FDA) certified as Class II medical devices and kill germs, viruses and bacteria.
Employees
-